Home › Core › ISCC-IDs › 28Cr9jWcyBb9y

View ISCC-ID

Core Data

28Cr9jWcyBb9y
ISCC-ID - digital asset identifier
CCjvGTSq57GSt-CTTZXmxJHqvFm-CDcCTMGyQuYFA-CRTh8ekLztwm3
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

p0813 a single pharmaceutic agent for molecular resection of glioblastoma

Ledger Reference

coblo
Source Ledger/Blockchain
12403196
N-th ISCC Decleration on source ledger
0794c4031fdf06be74b4ac97ecd84733f7727f634464c9ce126bb86f677fbd49
Hash of block that includes the ISCC-DECLARATION
35c5b089176f6456ace49e52df504b941c56355eafc045be9166df5bdced651c
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "P08.13 A single pharmaceutic agent for molecular resection of Glioblastoma", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "P. Sonawane", "@type": "Person"}, {"name": "D. Herpai", "@type": "Person"}, {"name": "S. Ferluga", "@type": "Person"}, {"name": "S. B. Tatter", "@type": "Person"}, {"name": "W. Debinski", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://academic.oup.com/neuro-oncology/article-pdf/19/suppl_3/iii56/17679124/nox036.203.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Oxford University Press (OUP)", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1093/neuonc/nox036.203", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCjvGTSq57GSt-CTTZXmxJHqvFm-CDcCTMGyQuYFA-CRTh8ekLztwm3", "propertyID": "ISCC"}], "datePublished": "2017-04-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close